• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

利妥昔单抗联合胸腔穿刺术成功治疗原发性年龄相关性EB病毒相关胸腔积液淋巴瘤。

Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis.

作者信息

Kuhlman Justin J, Alhaj Moustafa Muhamad, Tun Alexander J, Menke David M, Tun Han W, Jiang Liuyan

机构信息

Department of Internal Medicine Mayo Clinic Florida Jacksonville FL USA.

Division of Hematology and Medical Oncology Mayo Clinic Florida Jacksonville FL USA.

出版信息

Clin Case Rep. 2021 Apr 4;9(5):e03971. doi: 10.1002/ccr3.3971. eCollection 2021 May.

DOI:10.1002/ccr3.3971
PMID:34094552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8162398/
Abstract

EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.

摘要

EBV 阳性、HHV8 阴性的原发性渗出性淋巴瘤是 EBV 阳性弥漫性大 B 细胞淋巴瘤（NOS）谱系的一部分。该实体可被标记为原发性年龄相关 EBV 相关的原发性渗出性淋巴瘤，并且似乎对利妥昔单抗和胸腔穿刺术反应良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1f/8162398/947544105c9f/CCR3-9-e03971-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1f/8162398/f0179d10232c/CCR3-9-e03971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1f/8162398/947544105c9f/CCR3-9-e03971-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1f/8162398/f0179d10232c/CCR3-9-e03971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1f/8162398/947544105c9f/CCR3-9-e03971-g003.jpg

相似文献

1
Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis.利妥昔单抗联合胸腔穿刺术成功治疗原发性年龄相关性EB病毒相关胸腔积液淋巴瘤。
Clin Case Rep. 2021 Apr 4;9(5):e03971. doi: 10.1002/ccr3.3971. eCollection 2021 May.
2
Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy.原发性人疱疹病毒8型（-）基于渗出液的非生发中心B细胞弥漫性大B细胞淋巴瘤经标准蒽环类化疗免疫疗法成功治疗。
J Blood Med. 2021 Sep 9;12:833-838. doi: 10.2147/JBM.S328529. eCollection 2021.
3
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.EBV 阳性弥漫性大 B 细胞淋巴瘤，非特指类型：诊断、危险分层和治疗的 2018 更新。
Am J Hematol. 2018 Jul;93(7):953-962. doi: 10.1002/ajh.25112.
4
Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.基于腔隙的淋巴瘤：挑战与新观念。2022 年 EA4HP/SH 淋巴瘤研讨会报告。
Virchows Arch. 2023 Sep;483(3):299-316. doi: 10.1007/s00428-023-03599-2. Epub 2023 Aug 9.
5
Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.原发性人疱疹病毒8阴性渗出性淋巴瘤：一种预后良好的大B细胞淋巴瘤。
Blood Adv. 2020 Sep 22;4(18):4442-4450. doi: 10.1182/bloodadvances.2020002293.
6
HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases.达沙替尼治疗的慢性髓性白血病患者中出现的基于HHV8阴性积液的大B细胞淋巴瘤：两例报告
Biology (Basel). 2021 Feb 14;10(2):152. doi: 10.3390/biology10020152.
7
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management.EBV 阳性弥漫性大 B 细胞淋巴瘤，非特指类型：诊断、风险分层和管理的 2022 年更新。
Am J Hematol. 2022 Jul;97(7):951-965. doi: 10.1002/ajh.26579. Epub 2022 May 3.
8
HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review.慢性髓性白血病、达沙替尼治疗下 BCR::ABL1 阳性患者中 HHV8 阴性原发性渗出性大 B 细胞淋巴瘤：新病例报告及文献复习。
Diagn Cytopathol. 2022 Dec;50(12):E351-E356. doi: 10.1002/dc.25027. Epub 2022 Aug 2.
9
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management.EBV 阳性弥漫性大 B 细胞淋巴瘤，未另行指定：2020 年诊断、风险分层及管理更新
Am J Hematol. 2020 Apr;95(4):435-445. doi: 10.1002/ajh.25760. Epub 2020 Feb 29.
10
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.利妥昔单抗时代老年EB病毒阳性弥漫性大B细胞淋巴瘤的临床结局
Cancer Sci. 2014 Sep;105(9):1170-5. doi: 10.1111/cas.12467. Epub 2014 Sep 8.

引用本文的文献

1
Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy.原发性人疱疹病毒8型（-）基于渗出液的非生发中心B细胞弥漫性大B细胞淋巴瘤经标准蒽环类化疗免疫疗法成功治疗。
J Blood Med. 2021 Sep 9;12:833-838. doi: 10.2147/JBM.S328529. eCollection 2021.

本文引用的文献

1
Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.原发性人疱疹病毒8阴性渗出性淋巴瘤：一种预后良好的大B细胞淋巴瘤。
Blood Adv. 2020 Sep 22;4(18):4442-4450. doi: 10.1182/bloodadvances.2020002293.
2
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management.EBV 阳性弥漫性大 B 细胞淋巴瘤，未另行指定：2020 年诊断、风险分层及管理更新
Am J Hematol. 2020 Apr;95(4):435-445. doi: 10.1002/ajh.25760. Epub 2020 Feb 29.
3
Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
EB 病毒相关性 B 细胞淋巴组织增生性疾病和淋巴瘤：综述。
Pathology. 2020 Jan;52(1):40-52. doi: 10.1016/j.pathol.2019.09.006. Epub 2019 Nov 6.
4
Indolent primary effusion lymphoma-like lymphoma in the pericardium: A case report and review of the literature.心包内惰性原发性渗出性淋巴瘤样淋巴瘤：一例报告并文献复习
J Cardiol Cases. 2019 Jan 23;19(5):148-152. doi: 10.1016/j.jccase.2018.12.013. eCollection 2019 May.
5
HHV8-negative effusion based lymphoma: a series of 17 cases at a single institution.基于HHV8阴性积液的淋巴瘤：单机构17例病例系列
J Am Soc Cytopathol. 2015 Jan-Feb;4(1):37-43. doi: 10.1016/j.jasc.2014.10.002. Epub 2014 Oct 8.
6
Age and CD20 Expression Are Significant Prognostic Factors in Human Herpes Virus-8-negative Effusion-based Lymphoma.年龄和 CD20 表达是人类疱疹病毒-8 阴性渗出性淋巴瘤的重要预后因素。
Am J Surg Pathol. 2018 Dec;42(12):1607-1616. doi: 10.1097/PAS.0000000000001168.
7
Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.爱泼斯坦-巴尔病毒相关淋巴增殖性疾病：2016年世界卫生组织分类的综述与更新
J Pathol Transl Med. 2017 Jul;51(4):352-358. doi: 10.4132/jptm.2017.03.15. Epub 2017 Jun 5.
8
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.综述系列介绍：《世界卫生组织造血与淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2361-4. doi: 10.1182/blood-2016-03-657379. Epub 2016 Apr 11.
9
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
10
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.爱泼斯坦-巴尔病毒阳性弥漫性大B细胞淋巴瘤预后不良，与年龄无关。
Sci Rep. 2015 Jul 23;5:12168. doi: 10.1038/srep12168.